Literature DB >> 17382524

The 16 kDa subunit of vacuolar H+-ATPase is a novel sarcoglycan-interacting protein.

Jiwei Chen1, Mhairi A Skinner, Weixing Shi, Qian-Chun Yu, Alan G Wildeman, Yiu-mo Michael Chan.   

Abstract

The sarcoglycan complex in muscle consists of alpha-, beta-, gamma- and delta-sarcoglycan and is part of the larger dystrophin-glycoprotein complex (DGC), which is essential for maintaining muscle membrane integrity. Mutations in any of the four sarcoglycans cause limb-girdle muscular dystrophies (LGMD). In this report, we have identified a novel interaction between delta-sarcoglycan and the 16 kDa subunit c (16K) of vacuolar H(+)-ATPase. Co-expression studies in heterologous cell system revealed that 16K interacts specifically with delta-sarcoglycan and the highly related gamma-sarcoglycan through the transmembrane domains. In cultured C2C12 myotubes, 16K forms a complex with sarcoglycans at the plasma membrane. Loss of sarcoglycans in the sarcoglycan-deficient BIO14.6 hamster destabilizes the DGC and alters the localization of 16K at the sarcolemma. In addition, the steady state level of beta(1)-integrin is increased. Recent studies have shown that 16K also interacts directly with beta(1)-integrin and our data demonstrated that sarcoglycans, 16K and beta(1)-integrin were immunoprecipitated together in C2C12 myotubes. Since sarcoglycans have been proposed to participate in bi-directional signaling with integrins, our findings suggest that 16K might mediate the communication between sarcoglycans and integrins and play an important role in the pathogenesis of muscular dystrophy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17382524     DOI: 10.1016/j.bbadis.2007.01.014

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  7 in total

1.  The human papillomavirus type 16 E5 oncoprotein inhibits epidermal growth factor trafficking independently of endosome acidification.

Authors:  Frank A Suprynowicz; Ewa Krawczyk; Jess D Hebert; Sawali R Sudarshan; Vera Simic; Christopher M Kamonjoh; Richard Schlegel
Journal:  J Virol       Date:  2010-08-04       Impact factor: 5.103

Review 2.  The Dystrophin Complex: Structure, Function, and Implications for Therapy.

Authors:  Quan Q Gao; Elizabeth M McNally
Journal:  Compr Physiol       Date:  2015-07-01       Impact factor: 9.090

3.  Distinct pathophysiological mechanisms of cardiomyopathy in hearts lacking dystrophin or the sarcoglycan complex.

Authors:  DeWayne Townsend; Soichiro Yasuda; Elizabeth McNally; Joseph M Metzger
Journal:  FASEB J       Date:  2011-06-10       Impact factor: 5.191

4.  Abelson tyrosine kinase controls phagosomal acidification required for killing of Mycobacterium tuberculosis in human macrophages.

Authors:  Heiko Bruns; Frank Stegelmann; Mario Fabri; Konstanze Döhner; Ger van Zandbergen; Manfred Wagner; Mhairi Skinner; Robert L Modlin; Steffen Stenger
Journal:  J Immunol       Date:  2012-09-17       Impact factor: 5.422

5.  δ-Sarcoglycan-deficient muscular dystrophy: from discovery to therapeutic approaches.

Authors:  Alison M Blain; Volker W Straub
Journal:  Skelet Muscle       Date:  2011-03-17       Impact factor: 4.912

Review 6.  Aquaporin-4 Functionality and Virchow-Robin Space Water Dynamics: Physiological Model for Neurovascular Coupling and Glymphatic Flow.

Authors:  Tsutomu Nakada; Ingrid L Kwee; Hironaka Igarashi; Yuji Suzuki
Journal:  Int J Mol Sci       Date:  2017-08-18       Impact factor: 5.923

Review 7.  Sarcoglycanopathies: molecular pathogenesis and therapeutic prospects.

Authors:  Dorianna Sandonà; Romeo Betto
Journal:  Expert Rev Mol Med       Date:  2009-09-28       Impact factor: 5.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.